Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Jul 10, 2019)
Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019
This bill requires manufacturers of covered drugs under Medicare medical services to issue rebates to the Centers for Medicare & Medicaid Services. Rebates are calculated based on the number of units sold and the amount by which the manufacturer price exceeds inflation. The bill's requirements do not apply to drugs that cost less than $100 annually per user in 2020 (and as adjusted for inflation annually thereafter) or to drugs on a specified drug shortage list.
The bill also eliminates cost-sharing for such drugs for beneficiaries whose out-of-pocket costs meet or exceed a specified threshold.
What just happenedJul 10, 2019
Read twice and referred to the Committee on Finance.
Who’s behind it
- Introduced in SenateJul 10, 2019
- Jul 10, 2019IntroReferral
Read twice and referred to the Committee on Finance.
Finance Committee - Jul 10, 2019IntroReferral10000
Introduced in Senate